ArticleJournal of the American Academy of Dermatology2022
Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort study.
Abstract readMulticenter Study
In one paragraph
Article in Journal of the American Academy of Dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Epidemiology of Malignant Melanoma during the First Two Years of the COVID-19 Pandemic: A Systematic Review.International journal of environmental research and public health · 2022Pooled it
- Indirect Impact of Pandemic on the Diagnosis of New Primary Melanoma: A Retrospective, Multicenter Study.Journal of clinical medicine · 2025Article
- Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis.Cancers · 2024Review
- Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort study.Cancer medicine · 2023Article
- Impact of the COVID-19 Pandemic on Melanoma Diagnosis in Romania-Data from Two University Centers.International journal of environmental research and public health · 2022Article
- Patients' Experiences and Communication with Teledermatology versus Face-to-Face Dermatology.Journal of clinical medicine · 2022Article
- Dermatology and COVID-19: The Hidden Pandemic.Journal of clinical medicine · 2022Article
Corrections and comments
- Commented on by
Authors and funding
36 authors.
Nicole TrepanowskiBoston University School of Medicine, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Michael S ChangDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Guohai ZhouDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Maham AhmadDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Elizabeth G BerryDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
Katherine BuiDepartment of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
William H ButlerDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Emily Y ChuDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Clara Curiel-LewandrowskiDivision of Dermatology, The University of Arizona College of Medicine, Tucson, Arizona; The University of Arizona Cancer Center, Tucson, Arizona.
Laura E DellalanaDepartment of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
Darrel L EllisDepartment of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Dermatology, Nashville VA Medical Centers, Nashville, Tennessee.
S Caleb FreemanDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
Pavane L GorrepatiUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.
Douglas GrossmanDepartment of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah.
Samvel GyurdzhyanStanford University School of Medicine, Stanford, California.
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Amber Loren Ong KingDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Avani M KollaThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Christine G LianDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Jennifer Y LinDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Vincent LiuDepartments of Dermatology and Pathology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
Annie LowenthalDepartment of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah.
Kelly N McCoyUniversity of Virginia, Charlottesville, Virginia.
Ananya MunjalUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.
Caitlyn N MyrdalDivision of Dermatology, The University of Arizona College of Medicine, Tucson, Arizona.
Sara PerkinsDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Jennifer G PowersDepartment of Dermatology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
Corinne RauckDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Tristan C SmartDepartment of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah.
Jennifer A SteinThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Suraj VennaUniversity of Virginia School of Medicine, Charlottesville, Virginia; Inova Melanoma and Skin Cancer Center, Inova Schar Cancer Institute, Fairfax, Virginia.
Madalyn E WalshDepartment of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
Jennifer Y WangDepartment of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, California.
Sancy A LeachmanDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute at Oregon Health & Science University, Portland, Oregon.
Susan M SwetterDepartment of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, California; Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Rebecca I HartmanDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, VA Integrated Service Network (VISN-1), Jamaica Plain, Massachusetts. Electronic address: rhartman@bwh.harvard.edu.
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MViral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0MNCATS NIH HHS UL1 TR001863
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19MelanomaCohort StudiesHumansPandemicsSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.